Shyamapada Mandal

About

Dr. Shyamapada Mandal is Professor and (former) Head of the Department of Zoology, and (former) Dean of Science, University of Gour Banga, India. He is working on infectious diseases, probiotics, genomics, and small-molecule and peptide based drug development research. He did pre-PhD, PhD, and post-PhD research under the guidance of Professor Nishith Kumar Pal at the Calcutta School of Tropical Medicine, India. He has published 125 articles with eight book chapters. He is life member of IAMM and IASR, India, and fellow member of SASS, India. Eight national academic and research awards have been conferred to him. He has guided 58 post graduate students; supervised four MPhil and six PhD students, and supervising four PhD
students. Professor Mandal is among the world’s top 2% scientists as per the survey of the Stanford University, published in PLOS (Public Library of Science) Biology (October, 2020). He is featured in the top 2% world scientists list for the following years too, as published by the Stanford University-Elsevier BV (2021 to 2025).

Employment

• University of Gour Banga Professor
  2011 - Present

Education

• School of Tropical Medicine Ph D (Science)
  1999 - 2005

Projects & Funding

Projects & funding information is unavailable.

Publications (138)

• Synthesis, DNA-binding study and antibiotic properties of cationic bis-chalcones
  Journal of Molecular Structure 2026 DOI: 10.1016/j.molstruc.2026.147136
  +Save
• Anti-Staphylococcus aureus effectiveness of apigenin using in silico method combined with in vitro antibacterial activity analysis
  Kuwait Journal of Science 2026 DOI: 10.1016/j.kjs.2026.100655
  +Save
• Helicobacter pylori CagA virulence factor inhibition property of Hong Qi-derived active compounds by molecular docking and dynamics simulation combined with free energy landscape and ADME-Tox analysis
  Next Research 2026 DOI: 10.1016/j.nexres.2026.101355
  +Save
• Immunobioinformatic approaches for development of multi-epitope vaccine against mpox targeting attachment, entry-fusion and immune evasion proteins of mpox virus
  In Silico Research in Biomedicine 2026 DOI: 10.1016/j.insi.2026.100383
  +Save
• Molecular mechanism and multi-target inhibitory property of ruxolitinib as potential anti-SARS-CoV-2 agent: Network pharmacology study combined with molecular docking, molecular dynamics simulation and MM-PB(GB)SA analysis
  In Silico Research in Biomedicine 2026 DOI: 10.1016/j.insi.2025.100161
  +Save
• Bacterial taxonomic and functional diversity analysis by 16S-rRNA-based metagenomic next generation sequencing of sour curd from Malda, India
  Pharmacological Research - Natural Products 2025 DOI: 10.1016/j.prenap.2025.100404
  +Save
• Comparison of the rhizospheric soil bacteriomes of Oryza sativa and Solanum melongena crop cultivars reveals key genes and pathways involved in biosynthesis of ectoine, lysine, and catechol meta-cleavage
  Functional & Integrative Genomics 2025 DOI: 10.1007/s10142-025-01536-x
  +Save
• Antibacterial activity of caffeic acid from plant sources: A review based on in silico, in vitro and in vivo approaches
  The Microbe 2025 DOI: 10.1016/j.microb.2025.100541
  +Save
• Phytochemical profiles, biological activities and medicinal importance of Aloe vera L.: A review
  Journal of Holistic Integrative Pharmacy 2025 DOI: 10.1016/j.jhip.2025.07.001
  +Save
• Evaluation of inhibitory efficacy of plantaricin JK against NSP1 from SARS-CoV-2 by in silico methods
  Aspects of Molecular Medicine 2025 DOI: 10.1016/j.amolm.2025.100080
  +Save